Quick Answer
CervoMed Inc. reported Operating Income Loss of -$28.29 million for the year ending 2025.
- CervoMed Inc. showed a decrease of -55.2% in Operating Income Loss from 2024 to 2025.
- This data is from CervoMed Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2010 to 2025), CervoMed Inc.'s Operating Income Loss has declined by 270.5%.
- Historical annual values: Fiscal year 2025: -$28.29 million | Fiscal year 2024: -$18.23 million | Fiscal year 2023: -$7.81 million | Fiscal year 2022: -$3.48 million | Fiscal year 2021: -$24.68 million | Fiscal year 2020: -$15.97 million | Fiscal year 2019: -$11.55 million | Fiscal year 2018: -$18.96 million | Fiscal year 2017: -$11.35 million | Fiscal year 2016: -$18.37 million | Fiscal year 2015: -$6.41 million | Fiscal year 2014: -$14.61 million | Fiscal year 2013: -$12.80 million | Fiscal year 2011: -$16.43 million | Fiscal year 2010: -$7.64 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: